fullerene c60 has been researched along with transferrin in 2 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (transferrin) | Trials (transferrin) | Recent Studies (post-2010) (transferrin) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 17,596 | 554 | 3,141 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, L; Ji, Y; Jiao, X; Zhang, H; Zhang, Z; Zhu, X | 1 |
| Li, J; Sun, B; Wu, Z; Xing, X; Zhao, Y | 1 |
2 other study(ies) available for fullerene c60 and transferrin
| Article | Year |
|---|---|
Transferrin-mediated fullerenes nanoparticles as Fe(2+)-dependent drug vehicles for synergistic anti-tumor efficacy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Drug Delivery Systems; Drug Synergism; Endocytosis; Female; Fullerenes; Humans; Hyaluronic Acid; Intracellular Space; Iron; MCF-7 Cells; Mice, Inbred BALB C; Nanoparticles; Reactive Oxygen Species; Tissue Distribution; Transferrin | 2015 |
Metallofullerenol Inhibits Cellular Iron Uptake by Inducing Transferrin Tetramerization.
Topics: Biological Transport; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fullerenes; Gadolinium; Humans; Iron; Nanomedicine; Organometallic Compounds; Structure-Activity Relationship; Transferrin | 2017 |